Live price temporarily unavailable.
Encompass Health (EHC) is a Health Care company in the Russell 1000. Latest news and coverage below.
Encompass Health revenue & net income history (FY2016–FY2025)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.64B | $3.91B | $4.28B | $4.61B | $3.57B | $4.01B | $4.35B | $4.80B | $5.37B | $5.94B |
| Growth (year over year) | — | +7.4% | +9.3% | +7.7% | −22.6% | +12.6% | +8.3% | +10.4% | +11.9% | +10.5% |
| Operating income | $588.1M | $578.3M | $555.2M | $612.1M | $563.9M | $559.6M | $539.5M | — | — | — |
| Operating margin | 16.1% | 14.8% | 13.0% | 13.3% | 15.8% | 13.9% | 12.4% | — | — | — |
| Net income | $247.6M | $271.1M | $292.3M | $358.7M | $284.2M | $412.2M | $271.0M | $352.0M | $455.7M | $566.2M |
| Net margin | 6.8% | 6.9% | 6.8% | 7.8% | 8.0% | 10.3% | 6.2% | 7.3% | 8.5% | 9.5% |
| EPS (diluted) | $2.59 | $2.84 | $2.93 | $3.61 | $2.85 | $4.11 | $2.70 | $3.47 | $4.46 | $5.54 |
| Balance sheet | ||||||||||
| Cash and equivalents | $40.5M | $54.4M | $69.2M | $60.0M | $185.6M | $49.4M | $21.8M | $69.1M | $85.4M | $72.2M |
| Total assets | $4.68B | $4.86B | $5.17B | $6.08B | $6.45B | $6.86B | $5.64B | $6.10B | $6.53B | $7.09B |
| Total liabilities | $3.61B | $3.25B | $3.36B | $4.15B | $4.44B | $4.47B | $3.77B | $3.81B | $3.69B | $3.81B |
| Long-term debt | $2.98B | $2.55B | $2.48B | $3.02B | $3.25B | $3.24B | $2.74B | $2.69B | $2.36B | $2.45B |
| Shareholders' equity | $735.9M | $1.15B | $1.28B | $1.35B | $1.59B | $1.91B | $1.31B | $1.65B | $2.07B | $2.44B |
| Cash flow | ||||||||||
| Operating cash flow | $640.2M | $658.3M | $762.4M | $635.3M | $704.7M | $715.8M | $705.8M | $850.8M | $1.00B | $1.18B |
| Capital expenditure | $177.7M | $225.8M | $254.5M | $372.4M | $392.8M | $524.6M | $564.8M | $583.1M | $642.5M | $736.4M |
| Free cash flow | $462.5M | $432.5M | $507.9M | $262.9M | $311.9M | $191.2M | $141.0M | $267.7M | $360.3M | $439.2M |
| Dividends paid | $83.8M | $91.5M | $100.8M | $108.7M | $111.8M | $112.2M | $99.0M | $60.4M | $62.8M | $71.1M |
| Share buybacks | $65.6M | $38.1M | $0 | $45.9M | $6.10M | $0 | $0 | $0 | $31.1M | $158.0M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.35B | $1.41B | $1.46B | $1.46B | $1.48B | $1.54B | $1.59B | $1.60B |
| Growth (year over year) | +11.9% | +12.7% | +10.6% | +12.0% | +9.4% | +9.9% | +9.0% | +9.6% |
| Net income | $108.2M | $120.9M | $151.5M | $142.1M | $126.5M | $146.1M | $194.5M | $153.9M |
| Net margin | 8.0% | 8.6% | 10.4% | 9.7% | 8.6% | 9.5% | 12.3% | 9.6% |
| EPS (diluted) | $1.06 | $1.18 | $1.48 | $1.39 | $1.24 | $1.43 | $1.93 | $1.54 |
| Balance sheet | ||||||||
| Cash and equivalents | $147.8M | $85.4M | $95.8M | $99.1M | $48.7M | $72.2M | $110.5M | $107.7M |
| Total assets | $6.46B | $6.53B | $6.64B | $6.79B | $6.87B | $7.09B | $7.31B | $7.46B |
| Total liabilities | $3.73B | $3.69B | $3.70B | $3.70B | $3.68B | $3.81B | $3.95B | $4.00B |
| Long-term debt | $2.34B | $2.36B | $2.33B | $2.32B | $2.39B | $2.45B | $2.53B | $2.60B |
| Shareholders' equity | $1.96B | $2.07B | $2.16B | $2.28B | $2.37B | $2.44B | $2.52B | $2.60B |
| Cash flow | ||||||||
| Operating cash flow | $267.8M | $278.8M | $288.6M | $270.2M | $270.8M | $346.0M | $313.1M | $282.6M |
| Capital expenditure | $147.5M | $198.7M | $163.1M | $156.9M | $187.1M | $229.3M | $162.4M | $220.3M |
| Free cash flow | $120.3M | $80.1M | $125.5M | $113.3M | $83.7M | $116.7M | $150.7M | $62.3M |
| Dividends paid | $15.0M | $17.0M | $18.0M | $17.1M | $17.0M | $19.0M | $20.3M | $18.9M |
| Share buybacks | $6.80M | $7.50M | $32.1M | $24.7M | $24.9M | $76.3M | $71.6M | $74.2M |
From Encompass Health's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Encompass Health
Encompass Health Corporation, formerly Amcare and HealthSouth, based in Birmingham, Alabama, is the United States's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 173 inpatient rehabilitation hospitals located in 39 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.
Source: Wikipedia — Encompass Health
- Headquarters
- Birmingham, Alabama From SEC filings, Oct 2026
Recent News
No recent news mentioning Encompass Health in our feed yet.
Other Health Care companies to compare with EHC
- EBS Emergent Biosolutions Inc
- ECOR electroCore
- EDIT Editas Medicine Inc
- EHAB Enhabit Inc
- EIKN Eikon Therapeutics
- ELAN Elanco Animal Health
- ELDN Eledon Pharmaceuticals Inc
- ELMD Electromed Inc